Anti-Toxoplasma, Anti-rubella, and Anti-cytomegalovirus Antibodies in Dumpsite Workers of Erbil Governorate

DOI: https://doi.org/10.24086/cuesj.v3n1y2019.pp85-89
Keywords: Cytomegalovirus, dumpsite workers, municipal solid waste, rubella, solid waste disposal, Toxoplasma gondii

Abstract

The present study aimed to detect the presence of anti-Toxoplasma, anti-rubella, and anti-cytomegalovirus (CMV) antibodies in the sera of dumpsite workers of Erbil Governorate. Eighty nine male dumpsite (Kany Qrzhala, Erbil Governorate) workers were included in this study. Serum was obtained for the detection of anti-Toxoplasma, anti-rubella, and anti-CMV antibodies using an automated cobas e411 immunoassay analyzer. No anti-Toxoplasma IgM antibodies were detected in any of the workers’ sera, while (25.84%) showed a positive result for anti-Toxoplasma IgG antibodies. All workers’ sera had no anti-rubella IgM and IgG2 antibodies, while (62.92%) of them revealed the presence of IgG1 in their sera. Anti-CMV IgM was found in (2.25%) of the sera, while (13.50%) of the sera revealed the presence of anti-CMV IgG antibodies.

Downloads

Download data is not yet available.

References

J. Bünger, B. Schapper-Scheele, R. Hilgers and E. Hallier. “A 5-year follow-up study on respiratory disorders and lung function in workers exposed to organic dust from composting plants”. International Archives of Occupational and Environmental Health, vol. 80, pp. 306-312, 2007.

I. M. Wouters, S. Spaan, J. Douwes, G. Doekes and D. Heederik. “Overview of personal occupational exposure levels to inhalable dust, endototoxin, beta (1->3)-glucan and fungal extracellular polysaccharides in the waste management chain”. Annals of Occupational Hygiene, vol. 50, no. 1, pp. 39-53, 2006.

OJL. “Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the Protection of Workers from Risks Related to Exposure to Biological Agents at Work (Seventh Individual Directive within the Meaning of Article 16(1) of Directive 89/391/EEC), OJL 262, 17.10.2000, pp. 21-45, 2000.

J. Douwes, P. Thorne, N. Pearce and D. Heederik. “Bioaerosols health effects and exposure assessment: progress and prospects”. Annals of Occupational Hygiene, vol. 47, no. 3, pp. 187-200, 2003.

F. M. Schets, L. de Heer and A. M. de Roda Husman. “Coxiella burnetii in sewage water at sewage water treatment plants in Q fever epidemic area”. International Journal of Hygiene and Environmental Health, vol. 216, no. 6, pp. 698-702, 2013.

A. J. Cook, R. E. Gilbert, W. Buffolano, J. Zufferey and E. Petersen, P. A. Jenum, W. Foulon, A. E. Semprini and D. T. Dunn. “Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. European research network on congenital toxoplasmosis”. BMJ, vol. 321, pp. 142-147, 2000.

A. B. Ismael, D. Sekkai, C. Collin, D. Bout and M. N. Meralece. “The MIC3 gene of Toxoplasma gondii is a novel vaccine candidate against toxoplasmosis”. Infection and Immunity, vol. 71, pp. 6222-6228, 2003.

J. G. Montoya and O. Liesenfeld. “Toxoplasmosis”. Lancet, vol. 363, pp. 1965-1976, 2004.

C. Coulter, R. Wood and J. Robson. “Rubella infection in pregnancy”. Communicable Diseases Intelligence, vol. 23, pp. 93-96, 1999.

S. Stagno, M. E. Dworsky, R. E. Henderson, E. G. Moore, P. D. Walton and C. A. Alford. “Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection”. The New England Journal of Medicine, vol. 306, no. 16, pp. 945-949, 1982.

C. Shashi, U. Arora and A. Aggarwal. “Prevalence of IgM antibodies to Toxoplasma, rubella and cytomegalovirus infections during pregnancy”. JK Science, vol. 6, no. 4, 190-192, 2004.

J. Vidal. “Smelly, Contaminated, Full of Disease: The World’s Open Dumps are Growing”. Global Development, supported by Bill and Melinda Gates Foundation, 2017.

P. Singh. “Impact of solid waste on human health: A case study of Varanasi city”. International Journal of Scientific and Engineering Research, vol. 4, no. 11, pp. 1840-1842, 2013.

S. Rathi. “Alternative approaches for better municipal solid waste management in Mumbai, India”. Waste Management, vol. 26, no. 10, pp. 1192-1200, 2006.

M. Sharholy, K. Ahmad, R. C. Vaishya and R. D. Gupta. “Municipal solid waste characteristics and management in Allahabad, India”. Waste Management, vol. 27, pp. 490-496, 2007.

N. Gupta, K. K. Yadav and V. Kumar. “A review on current status of municipal solid waste management in India”. Journal of Environmental Sciences, vol. 37, pp. 206-217, 2015.

S. Laitinen and T. Rantio. “Exposure to Dangerous Substances in the Waste Management Sector”. Finnish Institute of Occupational Health, Finland. Available from: https://www.oshwiki.eu/wiki/Exposure_to_dangerous_substances_in_the_waste_management_sector. [Last accessed on 2019 Apr 01].

A. M. Tenter, A. R. Heckeroth and L. M. Weiss. Toxoplasma gondii: From animals to humans. International Journal for Parasitology, vol. 30, no. 12-13, p. 1217, 2000.

Test ID: TOXGP: Toxoplasma gondii Antibody, IgG. Mayo Clinic Laboratories. Available from: https://www.mayocliniclabs.com/test-catalog/Clinical+and+Interpretive/34972. [Last accessed on 2019 Apr 01].

American Academy of Pediatrics. Rubella. In Red Book. 2012 Report of the Committee on Infectious Diseases. Edited by LK Pickering, Elk Grove Village, IL, 2012.

Cytomegalovirus (CMV) Antibodies, IgM and IgG, Serum. Centra Care Laboratory Servicespowered by Mayo Clinic Laboratories. Available from: https://www.centracarelaboratoryservices.testcatalog.org/show/0205369-1; https://www.centracarelaboratoryservices.testcatalog.org/show/0205369-1. [Last accessed on 2019 Apr 01].

Published
2019-06-30
How to Cite
1.
Juma A, Ubeid M, Salih T. Anti-Toxoplasma, Anti-rubella, and Anti-cytomegalovirus Antibodies in Dumpsite Workers of Erbil Governorate. cuesj [Internet]. 30Jun.2019 [cited 28Mar.2023];3(1):85-9. Available from: https://journals.cihanuniversity.edu.iq/index.php/cuesj/article/view/98
Issue
Vol 3 No 1 (2019)
Section
Research Article

Copyright (c) 2019 Ameena S. M. Juma, Muhsin H. Ubeid, Tanya S. Salih

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).